[Experience with amysil treatment of patients with vascular parkinsonism]

The results of treatment of 45 patients with vascular parkinsonism are reported. To the majority of the patients, daily amysil administration (1-2 mg 2-4 times a day) was prescribed. Most pronounced was the drug effect in patients with combined syndromes in which predominated bradikynesia (79.3%), rigidity (75%), and to a lesser extent, tremor (66.6%). In some patients, the sedative effect was evident. In most of the patients, the positive EMG changes were noticeable, especially in those with stage I of the disease.